BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10505765)

  • 1. Variant of ductal adenocarcinoma of pancreas.
    Suda K; Nobukawa B; Mogaki M; Fujii H; Matsumoto Y
    Pancreas; 1999 Oct; 19(3):318-20. PubMed ID: 10505765
    [No Abstract]   [Full Text] [Related]  

  • 2. ADAM9 expression in pancreatic cancer is associated with tumour type and is a prognostic factor in ductal adenocarcinoma.
    Grützmann R; Lüttges J; Sipos B; Ammerpohl O; Dobrowolski F; Alldinger I; Kersting S; Ockert D; Koch R; Kalthoff H; Schackert HK; Saeger HD; Klöppel G; Pilarsky C
    Br J Cancer; 2004 Mar; 90(5):1053-8. PubMed ID: 14997207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of thymidine phosphorylase is associated with a poor prognosis in patients with ductal adenocarcinoma of the pancreas.
    Takao S; Takebayashi Y; Che X; Shinchi H; Natsugoe S; Miyadera K; Yamada Y; Akiyama S; Aikou T
    Clin Cancer Res; 1998 Jul; 4(7):1619-24. PubMed ID: 9676835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinction of Invasive Carcinoma Derived From Intraductal Papillary Mucinous Neoplasms From Concomitant Ductal Adenocarcinoma of the Pancreas Using Molecular Biomarkers.
    Tamura K; Ohtsuka T; Date K; Fujimoto T; Matsunaga T; Kimura H; Watanabe Y; Miyazaki T; Ohuchida K; Takahata S; Ishigami K; Oda Y; Mizumoto K; Nakamura M; Tanaka M
    Pancreas; 2016 Jul; 45(6):826-35. PubMed ID: 26646266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discrimination of CD44 and Oct3/4 Expression in Pancreatic Adenocarcinoma from Benign Pancreatic Ducts in Small Biopsy Specimens.
    Lee CC; Kuo WH; Lin CK; Gao HW; Tsai WC
    Chin J Physiol; 2017 Apr; 60(2):81-88. PubMed ID: 28464601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of SOX9 expression in pancreatic ductal adenocarcinoma and intraductal papillary mucinous neoplasm.
    Tanaka T; Kuroki T; Adachi T; Ono S; Hirabaru M; Soyama A; Kitasato A; Takatsuki M; Hayashi T; Eguchi S
    Pancreas; 2013 Apr; 42(3):488-93. PubMed ID: 23146920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sialylated MUC1 mucin expression in normal pancreas, benign pancreatic lesions, and pancreatic ductal adenocarcinoma.
    Masaki Y; Oka M; Ogura Y; Ueno T; Nishihara K; Tangoku A; Takahashi M; Yamamoto M; Irimura T
    Hepatogastroenterology; 1999; 46(28):2240-5. PubMed ID: 10521973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of polypotent cells in development of pancreatic tumors].
    Arkh Patol; 2006; 68(2):51-6. PubMed ID: 16752513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variant of intraductal carcinoma (with scant mucin production) is of main pancreatic duct origin: a clinicopathological study of four patients.
    Suda K; Hirai S; Matsumoto Y; Mogaki M; Oyama T; Mitsui T; Fujibayashi M; Kumazawa K; Kajiwara T
    Am J Gastroenterol; 1996 Apr; 91(4):798-800. PubMed ID: 8677955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic markers in pancreatic ductal adenocarcinomas.
    Hezel AF; Bardeesy N
    Cancer Biol Ther; 2008 Sep; 7(9):1360-1. PubMed ID: 18836287
    [No Abstract]   [Full Text] [Related]  

  • 11. Prognostic factors in ductal pancreatic cancer.
    Yeo CJ; Cameron JL
    Langenbecks Arch Surg; 1998 Apr; 383(2):129-33. PubMed ID: 9641885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic fibrosis associated with age and ductal papillary hyperplasia.
    Detlefsen S; Sipos B; Feyerabend B; Klöppel G
    Virchows Arch; 2005 Nov; 447(5):800-5. PubMed ID: 16021508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intraductal papillary mucinous neoplasm of pancreas: a clinicopathologic and immunohistochemical study of 19 cases].
    Huo Z; Yang D; Chang XY; Wan JW; Chen J
    Zhonghua Bing Li Xue Za Zhi; 2008 Oct; 37(10):670-5. PubMed ID: 19094485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased SOX9 Expression in Premalignant and Malignant Pancreatic Neoplasms.
    Gnerlich JL; Ding X; Joyce C; Turner K; Johnson CD; Chen H; Abood GJ; Pappas SG; Aranha GV
    Ann Surg Oncol; 2019 Feb; 26(2):628-634. PubMed ID: 30357576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intestinal type adenocarcinoma: a previously unrecognized histologic variant of ductal carcinoma of the pancreas.
    Albores-Saavedra J; Simpson K; Dancer YJ; Hruban R
    Ann Diagn Pathol; 2007 Feb; 11(1):3-9. PubMed ID: 17240300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of aquaporin water channels AQP1 and AQP5 in the ductal system of the human pancreas.
    Burghardt B; Elkaer ML; Kwon TH; Rácz GZ; Varga G; Steward MC; Nielsen S
    Gut; 2003 Jul; 52(7):1008-16. PubMed ID: 12801959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of fluorescence in situ hybridization in pancreatic ductal adenocarcinoma.
    Adsay NV; Dergham ST; Koppitch FC; Dugan MC; Mohamed AN; Vaitkevicius VK; Sarkar FH
    Pancreas; 1999 Mar; 18(2):111-6. PubMed ID: 10090407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A rare malformation of the pancreaticobiliary junction long common channel choledochal cyst and pancreas divisum in a patient with pancreatic cancer.
    Hünerbein M; Ghadimi BM; Benhidjeb T; Schlag PM
    Hepatogastroenterology; 1999; 46(27):1647-9. PubMed ID: 10430313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secretin receptors in normal and diseased human pancreas: marked reduction of receptor binding in ductal neoplasia.
    Körner M; Hayes GM; Rehmann R; Zimmermann A; Friess H; Miller LJ; Reubi JC
    Am J Pathol; 2005 Oct; 167(4):959-68. PubMed ID: 16192632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD133 expression pattern distinguishes intraductal papillary mucinous neoplasms from ductal adenocarcinomas of the pancreas.
    Shimizu K; Itoh T; Shimizu M; Ku Y; Hori Y
    Pancreas; 2009 Nov; 38(8):e207-14. PubMed ID: 19786935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.